This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1977.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1977
**Title: The Innovations of Franz Starey in Antihypertensive Research**
Introduction
Franz Starey, an esteemed inventor based in Frankfurt-am-Main, Germany, has made significant contributions to the field of medicinal chemistry. His research focus primarily involves the development of antihypertensive agents, specifically through his innovative work on substituted benzoic acid derivatives.
Latest Patents
Franz Starey holds one notable patent, which details a novel class of antihypertensively-active compounds. This patent introduces 3-sulfamoyl-4-piperazinyl-benzoic acids, which can be optionally substituted in the 2-position by halogen or alkyl groups. The patent also covers the esters, amides, and nitriles of these acids, presenting a method for synthesizing these compounds. The innovative synthesis involves the reaction between 4-halogeno- or 4-alkyl-(or 4-aryl-) sulfonyloxy-benzoic acids and piperazines, paving the way for the development of effective treatments for hypertension.
Career Highlights
Franz Starey has built a reputable career at Hoechst Aktiengesellschaft, where he has utilized his expertise in organic chemistry to advance pharmaceutical developments. His work has positioned him as a key player in the research of therapeutic agents aimed at treating high blood pressure, contributing to the broader field of cardiovascular health.
Collaborations
During his tenure, Starey has collaborated with notable colleagues, including Karl Sturm, enhancing the quality and impact of their research endeavors. These collaborations have fostered an environment of innovation, leading to significant advancements in therapeutic applications of their discoveries.
Conclusion
Through his patent and research at Hoechst Aktiengesellschaft, Franz Starey exemplifies the essential role inventors play in driving innovation in healthcare. His work continues to inspire future research, ultimately contributing to improved health outcomes for individuals suffering from hypertension. The legacy of his contributions to medicinal chemistry is one that underscores the importance of invention in the realm of pharmaceutical development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile